Research: CHM evaluation: Transient embryonic hypoxia and teratogenicity with HPTs
Imported from official source
MHRA assessment of transient embryonic hypoxia and teratogenicity in relation to oral hormone pregnancy tests (HPTs), as considered by the Commission on Human Medicines (CHM).
This version
- Version
- 1 of 1
- Recorded
- September 20, 2026 19:53
- Change
- Initial
- Content hash
3036fd45caa4b25fcfe15720cc1306c3- All versions
- Revision history